Marker | poverall | Alleles | Proband | Control | p | ||
---|---|---|---|---|---|---|---|
n | % | n | % | ||||
Only alleles with an observed frequency >5% in the patients were included in the analysis. | |||||||
*p<0.05, statistically significant. | |||||||
D2S1360 | 0.656 | 2 | 10 | 10 | 22 | 11.2 | 0.748 |
3 | 6 | 6 | 16 | 8.2 | 0.502 | ||
4 | 26 | 26 | 61 | 31.1 | 0.360 | ||
5 | 10 | 10 | 19 | 9.7 | 0.933 | ||
6 | 9 | 9 | 15 | 7.7 | 0.688 | ||
7 | 10 | 10 | 19 | 9.7 | 0.933 | ||
8 | 7 | 7 | 12 | 6.1 | 0.771 | ||
9 | 6 | 6 | 13 | 6.6 | 0.834 | ||
Other | 16 | 19 | |||||
D2S305 | 0.262 | 2 | 10 | 10 | 23 | 11.7 | 0.654 |
3 | 9 | 9 | 18 | 9.2 | 0.959 | ||
4 | 12 | 12 | 35 | 17.9 | 0.192 | ||
6 | 46 | 46 | 67 | 34.2 | 0.048* | ||
7 | 12 | 12 | 22 | 11.2 | 0.843 | ||
Other | 11 | 31 | |||||
D2S2233 | 0.048* | 2 | 10 | 10 | 36 | 18.4 | 0.060 |
4 | 13 | 13 | 43 | 21.9 | 0.063 | ||
5 | 9 | 9 | 18 | 9.2 | 0.959 | ||
6 | 13 | 13 | 26 | 13.3 | 0.949 | ||
7 | 32 | 32 | 42 | 21.4 | 0.047* | ||
8 | 12 | 12 | 11 | 5.6 | 0.052 | ||
9 | 7 | 7 | 14 | 7.1 | 0.964 | ||
Other | 4 | 6 | |||||
D2S2342 | 0.897 | 2 | 46 | 46 | 87 | 44.4 | 0.792 |
5 | 15 | 15 | 33 | 16.8 | 0.685 | ||
6 | 27 | 27 | 48 | 24.5 | 0.639 | ||
Other | 12 | 28 | |||||
D2S2201 | 0.476 | 1 | 6 | 6 | 9 | 4.6 | 0.601 |
5 | 8 | 8 | 17 | 8.7 | 0.844 | ||
7 | 6 | 6 | 15 | 7.7 | 0.600 | ||
8 | 64 | 64 | 112 | 57.1 | 0.256 | ||
9 | 7 | 7 | 12 | 6.1 | 0.771 | ||
Other | 9 | 31 |